5-Bromo-2'-deoxyuridine 5-溴-2-脱氧尿苷

CAS 59-14-3 MFCD00006529

化学结构图

59-14-3
SMILES: O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1Br

化学属性

Mol. FormulaC9H11BrN2O5
Mol. Weight307
Density1.905
Melting Point191-194
TSCAYes
SolubilitySoluble in water (10 mg/mL), NH4OH (0.1 M) at 20 °C, DMF, DMSO, and sodium hydroxide.
Appearance 白色结晶性粉末,无臭、无味。难溶于水和甲醇,几乎不溶于氯仿和苯,易溶于氢氧化钠溶液。mp193-197℃ (分解)。比旋度+23°(C=1,水中)。
Refractive index22 ° (C=1, H2O)
Stability对空气敏感

别名和识别编码

Chemical Name5-Bromo-2'-deoxyuridine
CAS Number59-14-3
Synonym (+)-5-Bromo-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione 1-(2-脱氧-Β-D-呋喃核糖基)-5-溴尿嘧啶 2'-Deoxy-5-bromouridine 2'-De 5-B 5-BRDU 5-BrdU 5-溴-1-(2-脱氧-β-D-呋喃核糖)尿嘧啶 5-溴脱氧尿苷 BUdR 5-BrdU, 5-Bromo-1-(2-deoxy-β-D-ribofuranosyl)uracil, 5-Bromouracil deoxyriboside, BUdR 5-Brom-2'-deoxyuridin 5-Bromouracil-2-deoxyriboside 5-Budr 5-bromo-2'-deoxy-uridine 5-bromouracildeoxyriboside 5-溴-2'-脱氧尿苷 5-溴-2'-脱氧尿苷;5'-溴尿嘧啶核苷;溴脲苷;5-溴-1-(2-脱氧-β 5-溴脱氧尿苷 BDU BRDU LABELING REAGENT Bromodeoxyuridine Broxuridine Uridine, 5-bromo-2'-deoxy- broxuridine (INN) {} {} {Ch {} {} {Chemi {} {} {uni_hamburg} 溴脲嘧啶苷 溴脲苷 脱氧溴
EC Number200-415-9
Beilstein Registry Number30395
MDL NumberMFCD00006529
PubChem Substance ID6035
Merck Number14,1452
Chemical Name Translation5-溴-2-脱氧尿苷
Reaxys-RN4236087
Wiswesser Line NotationT6NVMVJ EE A- ET5OTJ B1Q CQ
LabNetwork Molecule IDLN00189260
InChIInChI=1S/C9H11BrN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {uni_hamburg} no charge; oxygen heterocycle; nitrogen heterocycle; alicycle; 5ring; 6ring; urea; amid
  • Bases & Related Reagents
  • {SNA} Nucleoside Analogs, 核苷,核苷酸和寡核苷酸, 生化试剂
  • {SNA} Apoptosis and Cell Cycle, BRDU 细胞增殖检测试剂, Core Bioreagents, DNA Synthesis Inhibitors, DNA metabolism, Nucleosides and Nucleotides, Nucleotide Analogs, Reagents, Research Essentials, 核苷,核苷酸和寡核苷酸, 生化试剂, 癌症研究, 细胞信号转导和神经科学, 细胞分析, 细胞生物学
  • {SNA} BRDU 细胞增殖检测试剂, Core Bioreagents, Nucleosides and Nucleotides, Nucleotide Analogs, Research Essentials, 核苷

产品应用

  • 胸腺嘧啶类似物,在遗传学研究中用作诱变剂(mutagen),在细胞分裂的S-期选择性地插进DNA。

相关文献及参考

  • Merck:14,1452
  • Thymidine analog, preferentially incorporated into cellular DNA in place of thymidine, producing increased radiosensitivity of the cell: Int. J. Radiat. Oncol. Biol. Phys., 10, 1399 (1984); 21, 709 (1991). Mutagen used in genetic research: Mutat. Res., 258, 161 (1991). Reviews on use in diagnostics and research: Histochem. J., 27, 339, 923 (1995; 28, 531 (1996).
  • Short: EINECS
  • Fivan, A. L.: Flow Cytometry, First Principles, New York, (1992),
  • Short: III/5a
  • Merck:14,1452 Beilstein:24(3/4)1234
  • Boccadoro, M., et al.: Tumor, 72, 135 (1986),

安全信息

Signal word Danger
GHS Symbol
WGK Germany2
Safety Statements
  • S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
  • S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护;
  • S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
  • S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
Risk Statements
  • R46 May cause inheritable genetic damage 可能引起遗传基因损害
  • R61 May cause harm to the unborn child 可能对未出生的婴儿导致伤害
  • R68 Possible risk of irreversible effects 可能有不可挽回的作用的危险
Precautionary statements
  • P201 Obtain special instructions before use. 使用前获取专门指示。
  • P281 Use personal protective equipment as required. 使用所需的个人防护装备。
  • P308+P313
RTECSYU7350000
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
Hazard statements
  • H361 Suspected of damaging fertility or the unborn child 怀疑对生育能力或未出生婴儿造成伤害
  • H340 May cause genetic defects 可能导致遗传性缺陷
Hazard Codes T Xn
Storage condition -20℃保存 2-8°C
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 16 mg/kg
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Endocrine - thyroid tumors
   Reproductive - Tumorigenic effects - testicular tumors
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 295,113,1993

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 3500 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Cardiac - pulse rate
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   TAKHAA Takeda Kenkyusho Ho.  Journal of the Takeda Research Laboratories.
   (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532,
   Japan)  V.29-    1970-  Volume(issue)/page/year: 30,530,1971

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 3900 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Cardiac - pulse rate
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   TAKHAA Takeda Kenkyusho Ho.  Journal o

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Unreported
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 2300 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NIIRDN Drugs in Japan (Ethical Drugs).  (Yakugyo Jiho Co., Ltd., Tokyo,
   Japan)  Volume(issue)/page/year: 6,721,1982

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 2500 mg/kg
TOXIC EFFECTS :
   Behavioral - somnolence (general depressed activity)
   Cardiac - pulse rate
   Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
   TAKHAA Takeda Kenkyusho Ho.  Journal of the Takeda Research Laboratories.
   (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusohon-machi, Yodogawa-ku, Osaka 532,
   Japan)  V.29-    1970-  Volume(issue)/page/year: 30,530,1971

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Bacteria - Escherichia coli
DOSE/DURATION           : 10 mg/L
REFERENCE :
   GENTAE Genetics.  (Genetics Business Office, POB 64025, Baltimore, MD 21264)
    V.1-    1916-  Volume(issue)/page/year: 51,545,1965

TYPE OF TEST            : Sister chromatid exchange
TEST SYSTEM             : Human Testis
DOSE/DURATION           : 15 mg/L
REFERENCE :
   CYTBAI Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK)  V.1- 1969- 
   Volume(issue)/page/year: 38,159,1983

TYPE OF TEST            : Mutation test systems - not otherwise specified
TEST SYSTEM             : Microorganism - not otherwise specified
DOSE/DURATION           : 7500 ng/L
REFERENCE :
   JNCSAI Journal of Cell Science.  (Biochemical Soc. Book Depot, POB 32,
   Commerce Way, Colchester, Essex CO2 8HP, UK)  V.

TYPE OF TEST            : Sister chromatid exchange
TEST SYSTEM             : Human Ovary
DOSE/DURATION           : 20 mg/L
REFERENCE :
   CYTBAI Cytobios. (Faculty Press, 88 Regent St., Cambridge, UK)  V.1- 1969- 
   Volume(issue)/page/year: 38,159,1983

TYPE OF TEST            : Cytogenetic analysis
TEST SYSTEM             : Mammal - cattle Lymphocyte
DOSE/DURATION           : 20 mg/L
REFERENCE :
   CARYAB Caryologia.  (Via G. LaPira 4, 50121 Florence, Italy)  V.1-    1948-
   Volume(issue)/page/year: 36,285,1983

TYPE OF TEST            : DNA repair
TEST SYSTEM             : Bacteria - Escherichia coli
DOSE/DURATION           : 30 mg/L
REFERENCE :
   MGGEAE Molecular and General Genetics.  (Springer-Verlag, Heidelberger Pl.
   3, D-1000 Berlin 33, Fed. Rep. Ger.)  V.99-    1967-
   Volume(issue)/page/year: 171,135,1979

TYPE OF TEST            : Sister chromatid exchange
ROUTE OF EXPOSURE       : Subcutaneous
TEST SYSTEM             : Mammal - species unspecified
DOSE/DURATION           : 1 gm/k

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 600 mg/kg
SEX/DURATION            : female 8-13 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - delayed effects
REFERENCE :
   REPTED Reproductive Toxicology.  (Pergamon Press Inc., Maxwell House,
   Fairview Park, Elmsford, NY 10523)  V.1-    1987-  Volume(issue)/page/year:
   11,663,1997

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 200 mg/kg
SEX/DURATION            : female 8 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Specific Developmental Abnormalities - Central Nervous System
   Reproductive - Specific Developmental Abnormalities - eye/ear
REFERENCE :
   TAKHAA Takeda Kenkyusho Ho.  Journal of the Takeda Research Laboratories.
   (Takeda Yakuhin Kogyo K.K., 2-17-85 Jusoh

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Unreported
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 500 mg/kg
SEX/DURATION            : female 11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
   Reproductive - Specific Developmental Abnormalities - craniofacial
   (including nose and tongue)
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 34,412,1986

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intravenous

其他信息

  • 5-Bromo-2'-deoxyuridine is a thymidine analog. Useful for the study of DNA synthesis where it is incorporated into DNA in place of thymidine. 5-Bromo-2'-deoxyuridine can be used to label DNA. The resulting DNA can be used in conjunction with BrdU Monoclonal Antibody for the immunohistochemical analysis of cell proliferation.
  • 灭火剂:水,干粉,二氧化碳,泡沫,沙土
  • 类别:有毒物质
  • Alfa Aesar:5-溴-2'-脱氧尿苷,99% 5-Bromo-2'-deoxyuridine, 99%(59-14-3)
  • F:10-23
  • Sigma Aldrich:59-14-3(sigmaaldrich)
  • 急性毒性:口服-大鼠 LD50: 8400 毫克/公斤; 口服-小鼠 LD50: 9100 毫克/公斤
  • 毒性分级:低毒
  • 可燃性危险特性:热分解排出有毒氮氧化物和溴化物烟雾
  • TCI Shanghai:5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine,>;98.0%(LC)(T)(59-14-3)
  • 用途一:用于脑瘤和头颈部肿瘤的放射增敏剂,从而提高放疗效果。与抗代谢剂合用亦能提高疗效。
  • Acros Organics:5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine, 99+%(59-14-3)
  • 比旋光度:31 ° (c=1, 0.1N NaOH)
  • 图谱信息:溴脲苷(59-14-3)质谱(MS) 溴脲苷(59-14-3)红外图谱(IR2) 溴脲苷(59-14-3)红外图谱(IR1) 溴脲苷(59-14-3)核磁图( 13 CNMR) 溴脲苷(59-14-3)核磁图( 1 HNMR)
  • MOL 文件:59-14-3.mol
  • 储运特性:库房通风低温干燥
  • MSDS 信息:5-Bromo-2'-deoxyuridine(59-14-3).msds
  • 用途二:胸腺嘧啶类似物,在遗传学研究中用作诱变剂(mutagen),在细胞分裂的S-期选择性地插进DNA。
  • 溴脲苷价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 k1688001 5-溴-2’-脱氧尿苷(+4℃) 250mg 386元 2011/08/23 SB500201 5-溴-2’-脱氧尿苷(-20℃) 100mg 502元 2011/04/16 B1575 5-溴-2'-脱氧尿苷 5-Bromo-2'-deoxyuridine 1G 920元

系列性分类


相关产品推荐